Evinature, a pioneer in evidence-based nutraceutical formulations designed to support digestive health and help individuals manage chronic bowel challenges, today announced that its proprietary CurQD ...

Action Sports Jax’s Stuart Webber will be emceeing the Crohn’s & Colitis Take Steps! walk on Saturday, April 18.

Reganne O'Brien, Remarkable Woman overcomes ulcerative colitis, funds Woman In HER nonprofit ...

In patients with ulcerative colitis, initiation of biologic therapy within 12 months of diagnosis is linked to a lower risk for disease progression than later initiation.

Johnson & Johnson (NYSE: JNJ) today announced new long-term data from the QUASAR long-term extension (LTE) study showing that TREMFYA® (guselkumab) sustained clinical, endoscopic, and histologic ...

For some people with ulcerative colitis (UC), the symptoms are mild. But for others, symptoms can quickly turn into a medical emergency called fulminant colitis. Fulminant colitis is rare, affecting ...

The Crown Heights Crohns and Colitis Support will feature a leading physician, Dr. Michael Dolinger, who has revolutionized IBD care.

Researchers have used advanced genetic sequencing on a Brisbane family to identify a gene mutation linked to ulcerative colitis, a type of inflammatory bowel condition, sparking hopes of new ...

More than 80 percent of people with ulcerative colitis (UC) experience bowel urgency — that overwhelming, need-to-use-the-bathroom-right-now sensation. And for many, it’s one of the toughest parts of ...

With March marking National Colorectal Cancer Awareness Month, here’s what to know about colorectal cancer — including ...

More than 80% of those treated with TREMFYA® were in clinical remission and more than 50% were in endoscopic remission at Week 140 of the QUASAR long-term extension ...

These steps can help you take control of your ulcerative colitis diagnosis. Reviewed by Dietitian Katey Davidson, M.Sc.FN, RD, CPT A new ulcerative colitis (UC) diagnosis is a chance to take charge of ...